___

• 1. Dose M, Tempel H. Abuse potential of anticholinergics. Pharmacopsychiatry, 2000; 33(Sup. 1):43-6. 2. Hammon K, DeMartino BK. Postoperative delirium secondary to atropine premedication. Anesth Prog, 1985;32:107–8. 3. Holzgrafe RE, Vondrell JJ, Mintz SM. Reversal of postoperative reactions to scopolamine with physostigmine. Anesth Analg, 1973; 52:921–5. 4. Kaiser Stadler M, Altmayer P. Central anticholinergic syndrome after propofol anesthesia. Anasthesiol Intensivmed Notfallmed Schmerzther, 1995; 30:116–7. 5. Schultz U, Idelberger R, Rossaint R, Buhre W. Central anticholinergic syndrome in a child undergoing circumcision. Acta Anaesthesiol Scand, 2002; 46:224–6. 6. Hagemann HD, Prass D, Hausdorfer J. A case of central anticholinergic syndrome in pediatric anesthesia.Anaesthesist, 1988; 37:193–5. 7. Holland MS. Central anticholinergic syndrome in a pediatric patient following transdermal scopolamine patch placement. Nurse Anesth, 1992;3:121–4. 8. Grace RF. Benztropine abuse and overdose case report and review. Adverse Drug React Toxicol Rev. 1997;16: 103-12. 9. Katsanoulas K, Papaioannou A, Fraidakis O, Michaloudis D. Undiagnosed central anticholinergic syndrome may lead to dangerous complications. Eur J Anaesthesiol, 2000; 17: 466-7. 10. Longo VG. Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol Rev, 1966;18:965–96. 11. Kulka PJ, Toker H, Heim J, Joist A, Jakschik J. Suspected Central Anticholinergic Syndrome in a 6-Week-Old Infant. Anesth Analg, 2004; 99:1376 –8. 12. Schneck HJ, Rupreht J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta Anaesthesiol Belg, 1989:49: 219–28. 13. Hewer W, Biedert S. Delirium syndrome in biperiden poisoning. Fortschr Neurol Psychiatr, 1988;56: 133-6. 14. Köse R, Şahin ÖÖ, Abay E. Datura stramonium zehirlenmesine bağlı deliryum: Bir olgu. Anatolian Journal of Psychiatry, 2008;9: 54-7. 15. Duvoisin RC, Katz R. Reversal of central anticholinergic syndrome in man by physostigmine. JAMA, 1968:25: 1963–5. 16. Buchanan JF. Physostigmine as an antidote. Clin Toxicol Update, 1986;8:13-16. 17. Hartvig P, Wiklund L, Lindström B. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients.Acta Anaesthesiol Scand, 1986:30: 177–82. 18. Lauven PM, Calaminus JM. Antagonists in anesthesia. Anaesthesiol Intensivmed Notfallmed Schmerzther, 1995:30: 331–6. 19. Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME; Toxicology Investigators Consortium investigators. The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity. J Med Toxicol, 2015;11: 179-84. 20. Espi Martinez F, Espi Forcen F, Shapov A, Martinez Moya A. Biperiden dependence: case report and literature review. Case Rep Psychiatry, 2012;2012: 949256.